Navigation Links
NCPA Statement on CVS Caremark-Aetna Agreement
Date:7/29/2010

ALEXANDRIA, Va., July 29 /PRNewswire-USNewswire/ -- In response to the agreement announced that CVS Caremark would provide pharmacy benefits to all 9.7 million lives covered by insurance giant Aetna, the National Community Pharmacists Association (NCPA) issued the following statement from Arlington, Texas pharmacy owner and NCPA President Joseph H. Harmison, PD:

(Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100106/DC33253LOGO)

"When it comes to putting its profits before patients, CVS Caremark is quite simply in a league of its own. In seeking Federal Trade Commission approval of the merger of retail giant CVS with the major pharmacy benefit manager Caremark, pledged to be agnostic as to where patients filled their prescriptions. That pledge has rung hollow as patients and local pharmacists complain of greater and greater pressure – or outright mandates – to switch prescriptions to CVS stores or Caremark mail order.

"Two criticisms lodged against CVS Caremark since the merger would appear to be particularly relevant to the Aetna agreement. First, the utilization of sensitive, private medical information for crass, marketing pitches. Second, the imposition of the ironically named 'Maintenance Choice' program, which can force patients to endure unreasonable requirements for their prescription medication, such as significant waits for mail order or long trips to the nearest CVS. Both problems have the potential to plague additional patients as a result of this agreement.

"The cries of protest against compromised care and unreasonable restrictions on patient choice are likely to only grow louder and more frequent with this agreement. Regrettably, Aetna customers and patients can anticipate a barrage of misleading sales pitches and complex schemes intended to camouflage CVS Caremark's history of over-promising and under-delivering on pharmacy savings.

"The U.S. Federal Trade Commission's competition and privacy bureaus and at least 24 states and municipalities are investigating CVS Caremark regarding the many anticompetitive, anti-consumer complaints raised by patients, Members of Congress and independent community pharmacists. NCPA will continue to work to support these and other investigations in the hopes the regulators will see the need to implement meaningful changes to protect the patient's choice of pharmacy and to restore meaningful pharmacy competition."

The National Community Pharmacists Association (NCPA®) represents America's community pharmacists, including the owners of more than 22,700 independent community pharmacies, pharmacy franchises, and chains. Together they represent an $88 billion health-care marketplace, employ over 65,000 pharmacists, and dispense over 40% of all retail prescriptions. To learn more go to www.ncpanet.org or read NCPA's blog, The Dose, at http://ncpanet.wordpress.com.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
2. Statement From The National Conclave on HIV/AIDS Policy for Black Clergy
3. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
4. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
5. Statement of Andrea Kavanagh, Director, Pure Salmon Campaign, on the Science Sea Lice Study
6. Statement from the American Diabetes Association Related to ACCORD Trial Announcement
7. Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
8. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
9. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
10. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
11. VA Statement on Smoking Cessation Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... -- Indiso ltd , a medical technology company ... respiratory diseases announced today positive results in its clinical ... patients show improvements in respiratory functions and other clinical ... Upper and lower respiratory tract diseases and allergy ... reached epidemic level. Increasing number of studies however show ...
(Date:2/10/2016)... http://www.researchandmarkets.com/research/rp4pg8/molecular ) has ... Diagnostics Reports Bundle" report to their ... announced the addition of the "Molecular ... offering. --> Research and Markets ... of the "Molecular Diagnostics Reports Bundle" ...
(Date:2/10/2016)...  Cepheid (Nasdaq: CPHD ) today announced ... President and Chief Operating Officer, has been promoted ... Officer.  In his new capacity, Mr. Kocmond,s responsibilities ... Operations in addition to Manufacturing Operations, Engineering, Technical ... to report to John Bishop , Cepheid,s ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Colorado spine surgeon, ... of 334 spine surgeons to know in 2016 . The list consists of ... of spine surgery. , Dr. Corenman understands the importance of clinical excellence; he ...
(Date:2/11/2016)... ... February 11, 2016 , ... Dickinson Insurance & Financial Services continues their commitment ... in support of a local boy named Barrett, who has been fighting ALL leukemia ... and rally support for, all local families dealing with childhood cancer. Information on how ...
(Date:2/11/2016)... ... February 11, 2016 , ... From March ... Academy of Dermatology Annual Meeting at the Walter E. Washington Convention Center in ... for both the condition of hyperhidrosis (excessive sweating) and its treatment options. Specifically, ...
(Date:2/11/2016)... ... ... The book, “Computers Should Just Work!”, provides a basic, non-techie education on how ... signing a contract and how to spot an incompetent or dishonest IT person before ... and technology, it’s more important than ever to make sure the company you outsource ...
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th ... Molecular Imaging Congress (WMIC), will be held in New York City, NY on ... Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a greater ...
Breaking Medicine News(10 mins):